Saturday, October 3, 2026

EUR/CHF Is 1% Down In The Last 10 Sessions

ViaNews Editorial Team

October 12, 2023

EUR/CHF Is 1% Down In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.07% for the last 10 sessions. At 19:06 EST on Thursday, 12 October, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 0.505% up from its 52-week low and 5.299% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd continues to gain near 1.0610, focus on German, US data. According to FXStreet on Wednesday, 11 October, "On the other side, the uptick in German bond yields could limit the advancement of the EUR/USD pair, as market participants anticipate the European Central Bank (ECB) to pause its tightening cycle."
  • Eur/usd forex signal: inverted h&s pattern forms - 10 October 2023. According to DailyForex on Tuesday, 10 October, "Forex Brokers We Recommend in Your Region See full brokers list 1 Read full review Get Started BrokerGeoLists.push({type:'ReviewsNonPartner',id:'horizontal-top-5',size:5,fullReviewText:`Read full review`,getStartedText:`Get Started`,readReviewText:`Review`});Bullish viewBuy the EUR/USD pair and set a take-profit at 1.0650.", "The next EUR/USD news will be the upcoming Federal Reserve minutes and US consumer price index (CPI) data on Thursday. "
  • According to FXStreet on Wednesday, 11 October, "As long as the EUR/USD remains below the 200-day SMA, the potential for sustained downward pressure persists.", "The Euro (EUR) alternates gains with losses against the US Dollar (USD) on Wednesday, motivating EUR/USD to trade without a clear direction around the 1.0600 neighbourhood."
  • Eur/usd technical analysis: general trend is still bearish - 10 October 2023. According to DailyForex on Tuesday, 10 October, "But this trade can come back into action at any time and any bullish EUR/USD event should be viewed as a profit taking event in the opposite direction which is required to rebalance the market from previously extended positions.", "This stopped the EUR/USD pair's recent attempts to move upward towards the 1.0600 level at the end of last week's trading, and it settled lower around the 1.0530 support level at the time of writing the analysis. "
  • Eur/usd finds respite as US yields dip as traders eye US and German inflation data. According to FXStreet on Tuesday, 10 October, "A light economic calendar on both sides of the Atlantic keeps the EUR/USD entertained on US Dollar dynamics and market mood. ", "The drop in German bond yields is capping the EUR/USD advance on the Eurozone front, while the European Central Bank (ECB) is expected to halt its tightening cycle, according to market participants."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com